Literature DB >> 11708411

A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.

P Gordon1, J West, H Jones, T Gibson.   

Abstract

OBJECTIVE: To determine the 10 year outcome of hospital patients with established rheumatoid arthritis (RA) treated with disease modifying drugs (DMARD).
METHODS: All patients with RA of at least a year duration and attending a single clinician were followed prospectively for 10 years. DMARD treatments changed with time but were continued throughout. Measurements of joint tenderness (Ritchie Index), morning stiffness, grip, and disability (Health Assessment Questionnaire, HAQ) and radiographs of hands and feet were documented. A record of joint surgery was maintained. Patients who stopped attending the clinic were traced and an accurate record of deaths was obtained from the National Registry of Deaths. Paired clinical indices were compared where available between 0, 5, and 10 years.
RESULTS: At entry there were 289 patients of variable disease duration. Within 10 years, 71 had died (standardized mortality ratio 1.3) and 92 were alive but unavailable. Median joint tenderness, morning stiffness, grip strength, and hemoglobin were not significantly different at 0, 5, and 10 years. Erythrocyte sedimentation rate (ESR) declined but not significantly. By contrast, HAQ scores and radiographs worsened between 0 and 10 years (p = 0.0004, p = 0.0001, respectively). There was a trend toward lower ESR values and less disability and the lower radiographic scores in those with 10-15 years' disease duration in 1996 compared with those of similar duration in 1986. However, worsening of radiographs occurred in patients with short, medium, and long histories of RA. Correlations between disability, radiographic scores, and joint tenderness were apparent at the start and conclusion of the study. At 10 years, 54 (19%) of the original cohort had undergone at least one large joint replacement. Significantly more women required joint replacement surgery (chi-square 5.44, p = 0.02).
CONCLUSION: Over a 10 year period patients with RA exhibited an excess of deaths and a deterioration of radiographs and function despite regular DMARD treatment and apparent clinical containment. Worsening of radiographs occurred in both relatively early and late disease. There was a steady requirement for surgical large joint replacement with time. This study suggests that in the long term. the effect of DMARD treatments may be less than the expectations derived from short term studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708411

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Rheumatoid arthritis in 2003: where are we now with treatment?

Authors:  M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register.

Authors:  K Hyrich; D Symmons; K Watson; A Silman
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

3.  Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy.

Authors:  S M M Verstappen; J N Hoes; E J Ter Borg; J W J Bijlsma; A A M Blaauw; G A van Albada-Kuipers; C van Booma-Frankfort; J W G Jacobs
Journal:  Ann Rheum Dis       Date:  2006-05-05       Impact factor: 19.103

4.  Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.

Authors:  A Finckh; H K Choi; F Wolfe
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

5.  Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.

Authors:  Sigrid Odegård; Arnstein Finset; Petter Mowinckel; Tore K Kvien; Till Uhlig
Journal:  Ann Rheum Dis       Date:  2007-03-28       Impact factor: 19.103

Review 6.  Is rheumatoid arthritis really getting less severe?

Authors:  Till Uhlig; Tore K Kvien
Journal:  Nat Rev Rheumatol       Date:  2009-08       Impact factor: 20.543

Review 7.  Pursuit of optimal outcomes in rheumatoid arthritis.

Authors:  David L Scott
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.

Authors:  Bruno Laganà; Marta Vinciguerra; Raffaele D'Amelio
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

9.  The future of rheumatoid arthritis and hand surgery - combining evolutionary pharmacology and surgical technique.

Authors:  Malahias M; Gardner H; Hindocha S; Juma A; W Khan
Journal:  Open Orthop J       Date:  2012-02-23

Review 10.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.